INS and metabolic dysfunction-associated steatotic liver disease: The levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), low-density lipoprotein cholesterol (LDL-C), non-HDL-C, triglyceride (TG), insulin, TyG index, US-FLI, and liver stiffness measurement (LSM) were significantly elevated in the NAFLD group, whereas high-density lipoprotein cholesterol (HDL-C) levels were significantly decreased (P < 0.001).